CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Raphael Pharmaceutical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Raphael Pharmaceutical Inc
SUITE 105 - 5348 VEGAS DR.
Phone: (702) 442-1166p:702 442-1166 LAS VEGAS, NV  89108  United States Ticker: ESYE ESYE
On 2/20/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Easy Energy Inc for failure to make required periodic filings with the Commission.
Business Summary
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company. The Company is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The Company is in pre-clinical development stage for its lead product candidate, rheumatoid arthritis (RA), for the treatment of RA. In addition, the Company is also developing a pharmaceutical drug product for the treatment of hyperinflammatory syndrome inflammation related to COVID-19. The Company’s discovery platform focuses the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer ShlomiPilo 71
Chief Financial Officer, Director GuyOfir 52 9/27/2021 5/17/2007
Chief Technology Officer, Director IgalLouria-hayon 51 9/27/2021 9/27/2021
Independent Director YehudaEliya 50 9/27/2021 9/27/2021

Business Names
Business Name
Easy Energy Inc
Easy Energy Inc.
Easy Energy, Inc.
ESYE
RAPH
Raphael Pharmaceutical Ltd.

General Information
Outstanding Shares: 18,701,418 (As of 11/11/2024)
Shareholders: 192
Stock Exchange: OTC
Federal Tax Id: 260204284


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024